Page last updated: 2024-10-22

anthralin and Mast-Cell Sarcoma

anthralin has been researched along with Mast-Cell Sarcoma in 1 studies

Anthralin: An anthracene derivative that disrupts MITOCHONDRIA function and structure and is used for the treatment of DERMATOSES, especially PSORIASIS. It may cause FOLLICULITIS.
anthralin : An anthracene compound derived by the substitution of -OH groups for hydrogen at C-1 and C-8, and with an oxo group at C-9.

Mast-Cell Sarcoma: A unifocal malignant tumor that consists of atypical pathological MAST CELLS without systemic involvement. It causes local destructive growth in organs other than in skin or bone marrow.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Männistö, PT1
Vaissi, L1
Mustakallio, KK1
Viluksela, M1
Kosma, VM1
Collan, Y1

Other Studies

1 other study available for anthralin and Mast-Cell Sarcoma

ArticleYear
Tumor-producing activity of dithranol (anthralin) and two of its 10-acyl analogs in the dorsal skin of female NMRI mice.
    The Journal of pharmacology and experimental therapeutics, 1984, Volume: 229, Issue:1

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Topical; Animals; Anthracenes; Anthralin; Body Wei

1984